首页 > 最新文献

Health and Quality of Life Outcomes最新文献

英文 中文
Patients reported outcome of cognitive function scale: a psychometric evaluation.
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-02-12 DOI: 10.1186/s12955-025-02339-1
José Fernando Mora-Romo, Luis Alberto Mendoza-Contreras, Rafael Armando Samaniego-Garay, Isauro García-Alonzo, Filiberto Toledano-Toledano

Background: Assessment of cognitive function is essential to identify the impact of brain aging, disease or injury on individuals. The Short Form Cognitive Function Scale is a brief instrument, easy to use in clinical and research settings with simple interpretation. However, its psychometric properties have not been confirmed in the general Mexican population. The aim of this study was to determine the psychometric properties of the Short Form Cognitive Function Scale in the general Mexican population.

Methods: An instrumental design was conducted with 600 participants. Analyses were performed to evaluate factor structure (exploratory and confirmatory factor analysis), reliability (internal consistency), measurement invariance, construct validity (convergent and divergent) and Know-Groups Validity.

Results: A unifactorial structure of 8 items was verified with an internal consistency of α = 0.945 and a McDonald Omega index of Ω = 0.946. Measurement invariance was confirmed (ΔCFI & TLI ≤ 0.01; ΔRMSEA & SRMR ≤ 0.015), with respect to gender, age groups and geographic area of residence. Finally, the Short Form Cognitive Function Scale showed adequate convergent validity with the Subjective Well-Being variable (r =.507, p <.001), divergent with the GAD 5 (r = -.517, p <.001), and discriminant between younger and older participants (t = -5.304, p <.001).

Conclusions: The Short Form Cognitive Function Scale version for the general Mexican population presented adequate psychometric properties that make it a valid and reliable instrument for use in non-clinical and research settings in Mexico.

{"title":"Patients reported outcome of cognitive function scale: a psychometric evaluation.","authors":"José Fernando Mora-Romo, Luis Alberto Mendoza-Contreras, Rafael Armando Samaniego-Garay, Isauro García-Alonzo, Filiberto Toledano-Toledano","doi":"10.1186/s12955-025-02339-1","DOIUrl":"https://doi.org/10.1186/s12955-025-02339-1","url":null,"abstract":"<p><strong>Background: </strong>Assessment of cognitive function is essential to identify the impact of brain aging, disease or injury on individuals. The Short Form Cognitive Function Scale is a brief instrument, easy to use in clinical and research settings with simple interpretation. However, its psychometric properties have not been confirmed in the general Mexican population. The aim of this study was to determine the psychometric properties of the Short Form Cognitive Function Scale in the general Mexican population.</p><p><strong>Methods: </strong>An instrumental design was conducted with 600 participants. Analyses were performed to evaluate factor structure (exploratory and confirmatory factor analysis), reliability (internal consistency), measurement invariance, construct validity (convergent and divergent) and Know-Groups Validity.</p><p><strong>Results: </strong>A unifactorial structure of 8 items was verified with an internal consistency of α = 0.945 and a McDonald Omega index of Ω = 0.946. Measurement invariance was confirmed (ΔCFI & TLI ≤ 0.01; ΔRMSEA & SRMR ≤ 0.015), with respect to gender, age groups and geographic area of residence. Finally, the Short Form Cognitive Function Scale showed adequate convergent validity with the Subjective Well-Being variable (r =.507, p <.001), divergent with the GAD 5 (r = -.517, p <.001), and discriminant between younger and older participants (t = -5.304, p <.001).</p><p><strong>Conclusions: </strong>The Short Form Cognitive Function Scale version for the general Mexican population presented adequate psychometric properties that make it a valid and reliable instrument for use in non-clinical and research settings in Mexico.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"11"},"PeriodicalIF":3.2,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143406652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tools used to measure quality of life in adults with cystic fibrosis- a systematic review.
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-02-04 DOI: 10.1186/s12955-025-02338-2
Dorota Snop-Perkowska, Jakub Świtalski, Katarzyna Wnuk, Paweł Olszewski, Anna Augustynowicz

Background: Measuring the quality of life in patients with cystic fibrosis is important, both in terms of assessing the implementation of new therapies and monitoring their effects, as well as the ongoing evaluation of patients' condition. The objective of this study is to present tools for measuring the quality of life in adult patients with cystic fibrosis, along with their characteristics and measurement properties.

Methods: The systematic review was performed according to the PRISMA guidelines based on a previously prepared research protocol (PROSPERO: CRD42023491030). Searches were performed in Medline (via PubMed), Embase (via OVID), and Cochrane Library databases. In addition, manual searches of bibliographies from the studies included in the analysis and grey literature were performed. Quality assessment of the included studies was performed according to the guidelines of COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN).

Results: The systematic search identified 3,359 studies, of which 26 met the inclusion criteria for the analysis. Two publications were additionally included as a result of the manual search. A total of 16 tools for measuring the quality of life in adults with cystic fibrosis were identified, the measurement properties of which were presented in the included studies. Among these tools, the Cystic Fibrosis Questionnaire-Revised (CFQ-R) and the Cystic Fibrosis Quality of Life Questionnaire (CFQoL) were most frequently analyzed. There were also other new, promising tools.

Conclusion: Most studies reported acceptable measurement properties of tools used to measure quality of life in adult patients with cystic fibrosis. In many cases, however, significant limitations were observed related to the lack of comprehensive analysis of the factor structure and other aspects related to validation and responsiveness. There have also been problems with the reliability of some tool scales (including the CFQ-R 14+). The small number of studies makes it difficult to present clear conclusions regarding the usefulness of existing tools. In turn, new tools that may be used in economic analyses (CFQ-R-8 dimensions) or in individualized assessment of quality of life using a mobile application (Q-Life) seem promising. However, further research on large patient populations is necessary to analyze the measurement properties of all tools.

{"title":"Tools used to measure quality of life in adults with cystic fibrosis- a systematic review.","authors":"Dorota Snop-Perkowska, Jakub Świtalski, Katarzyna Wnuk, Paweł Olszewski, Anna Augustynowicz","doi":"10.1186/s12955-025-02338-2","DOIUrl":"10.1186/s12955-025-02338-2","url":null,"abstract":"<p><strong>Background: </strong>Measuring the quality of life in patients with cystic fibrosis is important, both in terms of assessing the implementation of new therapies and monitoring their effects, as well as the ongoing evaluation of patients' condition. The objective of this study is to present tools for measuring the quality of life in adult patients with cystic fibrosis, along with their characteristics and measurement properties.</p><p><strong>Methods: </strong>The systematic review was performed according to the PRISMA guidelines based on a previously prepared research protocol (PROSPERO: CRD42023491030). Searches were performed in Medline (via PubMed), Embase (via OVID), and Cochrane Library databases. In addition, manual searches of bibliographies from the studies included in the analysis and grey literature were performed. Quality assessment of the included studies was performed according to the guidelines of COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN).</p><p><strong>Results: </strong>The systematic search identified 3,359 studies, of which 26 met the inclusion criteria for the analysis. Two publications were additionally included as a result of the manual search. A total of 16 tools for measuring the quality of life in adults with cystic fibrosis were identified, the measurement properties of which were presented in the included studies. Among these tools, the Cystic Fibrosis Questionnaire-Revised (CFQ-R) and the Cystic Fibrosis Quality of Life Questionnaire (CFQoL) were most frequently analyzed. There were also other new, promising tools.</p><p><strong>Conclusion: </strong>Most studies reported acceptable measurement properties of tools used to measure quality of life in adult patients with cystic fibrosis. In many cases, however, significant limitations were observed related to the lack of comprehensive analysis of the factor structure and other aspects related to validation and responsiveness. There have also been problems with the reliability of some tool scales (including the CFQ-R 14+). The small number of studies makes it difficult to present clear conclusions regarding the usefulness of existing tools. In turn, new tools that may be used in economic analyses (CFQ-R-8 dimensions) or in individualized assessment of quality of life using a mobile application (Q-Life) seem promising. However, further research on large patient populations is necessary to analyze the measurement properties of all tools.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"10"},"PeriodicalIF":3.2,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the validity and reliability of the Indonesian version of Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Scale v1.2.
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-31 DOI: 10.1186/s12955-025-02336-4
Vitriana Biben, Farida Arisanti, Efi Fitriana, Erika Maklun, Vindy Margaretha Miguna, Nabilla Fikria Alviani

Background: The assessment of Health-Related Quality of Life (HRQoL) is essential in clinical outcomes, focusing on the subjective perception of individuals regarding the physical, mental, and social aspects of health status. However, conducting a large-scale HRQoL assessment poses various challenges that necessitate the development of a non-burdensome instrument. One promising solution is adapting Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Scale v1.2 through translation, validation, and cross-cultural testing for non-English populations. Therefore, this study aimed to evaluate the validity and reliability of the Indonesian version of PROMIS Global Health Scale for comprehensive HRQoL assessment.

Method: This cross sectional study involved a total of 343 participants, comprising patients, caregivers, and residents of Physical Medicine and Rehabilitation. PROMIS Global Health Scale v1.2 was subjected to translation and cultural adaptation using the Functional Assessment of Chronic Illness Therapy (FACIT) method. Content validity was tested by five experts using the Scale-Content Validity Index (S-CVI), and structural validity was evaluated through Confirmatory Factor Analysis (CFA). Internal consistency and test-retest reliability were examined using Cronbach's Alpha and intraclass correlation coefficient (ICC), respectively.

Result: The Indonesian version of PROMIS Global Health Scale v1.2 showed strong validity and reliability. Content validity analysis produced a S-CVI/Universal Agreement of 0.90 with item analysis factor loading's of > 0.3. Structural validity results were χ2/df (1.53), RMSEA (0.04), RMR (0.03), and CFI (0.99). The reliability results showed that Cronbach's Alpha for Global Physical Health (GPH) and Global Mental Health (GMH) was 0.61 and 0.77, respectively. Test-retest reliability assessment performed using intraclass correlation coefficients generated values of 0.72 for GPH (95% CI, [0.65,0.78])and 0.70 (95% CI [0.63,0.76]) for GMH.

Conclusion: The Indonesian version of PROMIS Global Health Scale v1.2 showed sufficient content validity, structural validity, internal consistency, and reliability, which supported the application of this tool for HRQoL assessment in clinical and research settings.

{"title":"Assessing the validity and reliability of the Indonesian version of Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Scale v1.2.","authors":"Vitriana Biben, Farida Arisanti, Efi Fitriana, Erika Maklun, Vindy Margaretha Miguna, Nabilla Fikria Alviani","doi":"10.1186/s12955-025-02336-4","DOIUrl":"10.1186/s12955-025-02336-4","url":null,"abstract":"<p><strong>Background: </strong>The assessment of Health-Related Quality of Life (HRQoL) is essential in clinical outcomes, focusing on the subjective perception of individuals regarding the physical, mental, and social aspects of health status. However, conducting a large-scale HRQoL assessment poses various challenges that necessitate the development of a non-burdensome instrument. One promising solution is adapting Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health Scale v1.2 through translation, validation, and cross-cultural testing for non-English populations. Therefore, this study aimed to evaluate the validity and reliability of the Indonesian version of PROMIS Global Health Scale for comprehensive HRQoL assessment.</p><p><strong>Method: </strong>This cross sectional study involved a total of 343 participants, comprising patients, caregivers, and residents of Physical Medicine and Rehabilitation. PROMIS Global Health Scale v1.2 was subjected to translation and cultural adaptation using the Functional Assessment of Chronic Illness Therapy (FACIT) method. Content validity was tested by five experts using the Scale-Content Validity Index (S-CVI), and structural validity was evaluated through Confirmatory Factor Analysis (CFA). Internal consistency and test-retest reliability were examined using Cronbach's Alpha and intraclass correlation coefficient (ICC), respectively.</p><p><strong>Result: </strong>The Indonesian version of PROMIS Global Health Scale v1.2 showed strong validity and reliability. Content validity analysis produced a S-CVI/Universal Agreement of 0.90 with item analysis factor loading's of > 0.3. Structural validity results were χ2/df (1.53), RMSEA (0.04), RMR (0.03), and CFI (0.99). The reliability results showed that Cronbach's Alpha for Global Physical Health (GPH) and Global Mental Health (GMH) was 0.61 and 0.77, respectively. Test-retest reliability assessment performed using intraclass correlation coefficients generated values of 0.72 for GPH (95% CI, [0.65,0.78])and 0.70 (95% CI [0.63,0.76]) for GMH.</p><p><strong>Conclusion: </strong>The Indonesian version of PROMIS Global Health Scale v1.2 showed sufficient content validity, structural validity, internal consistency, and reliability, which supported the application of this tool for HRQoL assessment in clinical and research settings.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"9"},"PeriodicalIF":3.2,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between social support, functional outcomes and health-related quality of life in working-aged adults at three months after ischemic stroke: results from the FRAILTY study.
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-27 DOI: 10.1186/s12955-025-02337-3
Elena Gurková, Daniela Bartoníčková, Daniel Šaňák, Šárka Šaňáková, Jana Zapletalová, Lenka Štureková

Background: The relationship between social support and functional outcomes and health-related quality of life (HRQoL) after ischemic stroke (IS) remains unclear, especially in working-aged patients.

Aim: To assess the relationship between perceived social support, functional outcomes, post-stroke psychosocial symptoms, and HRQoL in working-aged adults three months after IS.

Methods: A prospective and correlational design was used. Patients of working age (18-65 years) admitted for first-ever IS were enrolled in the prospective FRAILTY (Factors Affecting the Quality of Life After Ischemic Stroke in Young Adults) study (NCT04839887). HRQoL (using the Stroke Impact Scale, Quality of Life in Neurological Disorders), social support (using the Multidimensional Scale of Perceived Social Support), functional outcomes (using a modified Rankin Scale-mRS), and post-stroke psychosocial symptoms were assessed three months after IS. Descriptive statistics, Wilcoxon signed-rank test, Spearman's correlations and multiple linear regression were used for analysis.

Results: A total of 121 (54.5% males, mean age 51.7 ± 8.4 years) IS patients were analyzed. Of those, 87.7% had excellent clinical outcomes (mRS 0-1) after three months. Patients reported significant improvement in all domains of self-reported HRQoL except memory and communication after three months. The overall perceived social support was not associated with HRQoL domains. Post-stroke depression was negatively associated with all domains of HRQoL. Living arrangements (living alone) and post-stroke depression were negatively associated with perceived social support after IS.

Conclusions: More insight into the relationship between variables of HRQoL in working-aged adults might increase their social participation, strengthen supportive relationships, and promote their recovery and rehabilitation process. Focusing on the management of emotional problems and supporting functional outcomes may be modifiable factors that may represent targets for strategies to improve the HRQoL. Further research is needed to clarify the relationship between pre-stroke perceived social support and its types and post-stroke psychosocial symptoms in the long term.

{"title":"Relationship between social support, functional outcomes and health-related quality of life in working-aged adults at three months after ischemic stroke: results from the FRAILTY study.","authors":"Elena Gurková, Daniela Bartoníčková, Daniel Šaňák, Šárka Šaňáková, Jana Zapletalová, Lenka Štureková","doi":"10.1186/s12955-025-02337-3","DOIUrl":"10.1186/s12955-025-02337-3","url":null,"abstract":"<p><strong>Background: </strong>The relationship between social support and functional outcomes and health-related quality of life (HRQoL) after ischemic stroke (IS) remains unclear, especially in working-aged patients.</p><p><strong>Aim: </strong>To assess the relationship between perceived social support, functional outcomes, post-stroke psychosocial symptoms, and HRQoL in working-aged adults three months after IS.</p><p><strong>Methods: </strong>A prospective and correlational design was used. Patients of working age (18-65 years) admitted for first-ever IS were enrolled in the prospective FRAILTY (Factors Affecting the Quality of Life After Ischemic Stroke in Young Adults) study (NCT04839887). HRQoL (using the Stroke Impact Scale, Quality of Life in Neurological Disorders), social support (using the Multidimensional Scale of Perceived Social Support), functional outcomes (using a modified Rankin Scale-mRS), and post-stroke psychosocial symptoms were assessed three months after IS. Descriptive statistics, Wilcoxon signed-rank test, Spearman's correlations and multiple linear regression were used for analysis.</p><p><strong>Results: </strong>A total of 121 (54.5% males, mean age 51.7 ± 8.4 years) IS patients were analyzed. Of those, 87.7% had excellent clinical outcomes (mRS 0-1) after three months. Patients reported significant improvement in all domains of self-reported HRQoL except memory and communication after three months. The overall perceived social support was not associated with HRQoL domains. Post-stroke depression was negatively associated with all domains of HRQoL. Living arrangements (living alone) and post-stroke depression were negatively associated with perceived social support after IS.</p><p><strong>Conclusions: </strong>More insight into the relationship between variables of HRQoL in working-aged adults might increase their social participation, strengthen supportive relationships, and promote their recovery and rehabilitation process. Focusing on the management of emotional problems and supporting functional outcomes may be modifiable factors that may represent targets for strategies to improve the HRQoL. Further research is needed to clarify the relationship between pre-stroke perceived social support and its types and post-stroke psychosocial symptoms in the long term.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"8"},"PeriodicalIF":3.2,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11773794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143052294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimating health state utilities for aromatic L-amino acid decarboxylase deficiency (AADCd) in the United States.
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-23 DOI: 10.1186/s12955-025-02335-5
Berrin Monteleone, Katie Forster, Gin Nie Chua, Rongrong Zhang, Andrew Lloyd, Paul Castellano, Ioannis Tomazos

Background: AADCd is a rare neurometabolic disorder presenting in infancy. Children with AADCd have motor dysfunction and development delays that result in the need for lifelong care; quality of life is greatly impacted. Current characterizations of health-related quality of life and associated health state utilities (HSUs) may be underestimated in AADCd. Accurate characterization of AADCd burden is important when evaluating the benefits of treatment, especially the improvements observed with the recently approved disease-modifying therapy eladocagene exuparvovec. Time-trade-off (TTO) vignette methods may be used to elicit HSUs in AADCd for assessing the value of new treatments. This study aimed to first update previously published health state vignettes, then estimate AADCd HSUs in the United States (US).

Methods: Existing vignettes for five AADCd health states were updated based on the review of published literature and clinician/caregiver input. Health states included: "bedridden/no motor function," "head control," "sitting unassisted," "standing with support," "walking with assistance." Online composite TTO interviews were conducted 1:1 with adults from the US general public. Participants ranked health states in order of preference using a visual analog scale, then were presented with health state vignettes to elicit utilities using TTO. Mean TTO scores were calculated for each health state, and regression models were used to estimate disutility associated with use of feeding tube.

Results: Following revision of the vignettes, 120 participants completed the TTO task (mean age: 47 years; 50% female; 70% White); characteristics were not significantly different from US population norms in terms of age, sex, race or ethnicity. Six participants who appeared to misunderstand the exercise were excluded. Mean (SD) HSUs were: -0.258 (0.534) for bedridden state, -0.155 (0.569) for head control, 0.452 (0.523) for sitting unassisted, 0.775 (0.242) for standing with support, and 0.796 (0.235) for walking with assistance. The need for a feeding tube was associated with a disutility of 0.07.

Conclusions: This study implemented TTO methods to estimate utilities for five health states which reflect the burden and impact of AADCd. The range in values from the most to least severe health state suggests that there is potential for effective treatments to substantially improve quality of life in these patients.

{"title":"Estimating health state utilities for aromatic L-amino acid decarboxylase deficiency (AADCd) in the United States.","authors":"Berrin Monteleone, Katie Forster, Gin Nie Chua, Rongrong Zhang, Andrew Lloyd, Paul Castellano, Ioannis Tomazos","doi":"10.1186/s12955-025-02335-5","DOIUrl":"https://doi.org/10.1186/s12955-025-02335-5","url":null,"abstract":"<p><strong>Background: </strong>AADCd is a rare neurometabolic disorder presenting in infancy. Children with AADCd have motor dysfunction and development delays that result in the need for lifelong care; quality of life is greatly impacted. Current characterizations of health-related quality of life and associated health state utilities (HSUs) may be underestimated in AADCd. Accurate characterization of AADCd burden is important when evaluating the benefits of treatment, especially the improvements observed with the recently approved disease-modifying therapy eladocagene exuparvovec. Time-trade-off (TTO) vignette methods may be used to elicit HSUs in AADCd for assessing the value of new treatments. This study aimed to first update previously published health state vignettes, then estimate AADCd HSUs in the United States (US).</p><p><strong>Methods: </strong>Existing vignettes for five AADCd health states were updated based on the review of published literature and clinician/caregiver input. Health states included: \"bedridden/no motor function,\" \"head control,\" \"sitting unassisted,\" \"standing with support,\" \"walking with assistance.\" Online composite TTO interviews were conducted 1:1 with adults from the US general public. Participants ranked health states in order of preference using a visual analog scale, then were presented with health state vignettes to elicit utilities using TTO. Mean TTO scores were calculated for each health state, and regression models were used to estimate disutility associated with use of feeding tube.</p><p><strong>Results: </strong>Following revision of the vignettes, 120 participants completed the TTO task (mean age: 47 years; 50% female; 70% White); characteristics were not significantly different from US population norms in terms of age, sex, race or ethnicity. Six participants who appeared to misunderstand the exercise were excluded. Mean (SD) HSUs were: -0.258 (0.534) for bedridden state, -0.155 (0.569) for head control, 0.452 (0.523) for sitting unassisted, 0.775 (0.242) for standing with support, and 0.796 (0.235) for walking with assistance. The need for a feeding tube was associated with a disutility of 0.07.</p><p><strong>Conclusions: </strong>This study implemented TTO methods to estimate utilities for five health states which reflect the burden and impact of AADCd. The range in values from the most to least severe health state suggests that there is potential for effective treatments to substantially improve quality of life in these patients.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"7"},"PeriodicalIF":3.2,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11756132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143058949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Voice-related quality of life after total laryngectomy: a scoping review of recent evidence. 全喉切除术后与声音相关的生活质量:近期证据的范围回顾。
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-21 DOI: 10.1186/s12955-025-02334-6
Tatiana Pourliaka, Efcharis Panagopoulou, Vassiliki Siafaka

Background: Laryngeal cancer often leads to total laryngectomy (TL), which results in the loss of natural voice, necessitates voice rehabilitation and affects the individuals Quality of Life (QoL). Despite advancements in treatment, Voice-Related QoL (VRQoL) post TL remains a neglected area in the field of rehabilitation. This study seeks to fill this gap by evaluating though a scoping review the impacts of TL on patients' voice-related QoL.

Methods: A scoping review was conducted to assess the impact of total laryngectomy (TL) on voice-related quality of life (VRQoL). The search was performed across various electronic databases-PubMed, Scopus, Embase, Cohrane Library, Google scholar and Web of Science- using a broad set of keywords to capture studies addressing total laryngectomy and voice-related quality of life (VRQoL). Articles were screened using predefined inclusion and exclusion criteria, focusing on studies that directly addressed TL and VRQoL outcomes.

Results: A total of eleven papers were finally selected to respond to the research question. The review indicates that TL significantly impacts VRQoL. Common issues included difficulties with communication in noisy environments, social interactions, anxiety about being understood, and physical challenges related to voice production. These difficulties were reflected in lower scores on various assessment tools. Patients reported declines in socio-emotional functioning and faced challenges in physical activities requiring voice use.

Conclusions: This scoping review highlights the profound impact of TL on patients' voice-related QoL. Despite advances in surgical techniques and rehabilitation methods, patients continue to experience significant challenges in communication and social integration, which are crucial components of overall well-being. The persistent lower scores across various QoL assessment tools underscore the necessity for enhanced supportive care and innovative rehabilitation strategies tailored to the specific needs of this population.

背景:喉癌常导致全喉切除术(TL),导致自然语音丧失,需要语音康复,影响个体的生活质量(QoL)。尽管在治疗方面取得了进步,但语音相关生活质量(VRQoL)在康复领域仍然是一个被忽视的领域。本研究旨在填补这一空白,通过评估通过范围审查对患者的声音相关生活质量的影响。方法:回顾性分析全喉切除术(TL)对语音相关生活质量(VRQoL)的影响。检索是在各种电子数据库中进行的——pubmed, Scopus, Embase, Cohrane Library,谷歌scholar和Web of Science——使用一组广泛的关键词来捕获有关全喉切除术和语音相关生活质量(VRQoL)的研究。使用预定义的纳入和排除标准筛选文章,重点关注直接涉及TL和VRQoL结果的研究。结果:最终选择了11篇论文来回答研究问题。结果表明,TL对VRQoL有显著影响。常见的问题包括在嘈杂的环境中沟通困难、社交互动困难、对被理解的焦虑以及与发声相关的身体挑战。这些困难反映在各种评估工具的较低分数上。患者报告社会情感功能下降,并且在需要使用声音的身体活动中面临挑战。结论:本综述强调了TL对患者语音相关生活质量的深远影响。尽管手术技术和康复方法取得了进步,但患者在沟通和社会融合方面仍然面临重大挑战,这是整体健康的关键组成部分。各种生活质量评估工具的持续较低得分强调了加强支持性护理和针对这一人群特定需求的创新康复策略的必要性。
{"title":"Voice-related quality of life after total laryngectomy: a scoping review of recent evidence.","authors":"Tatiana Pourliaka, Efcharis Panagopoulou, Vassiliki Siafaka","doi":"10.1186/s12955-025-02334-6","DOIUrl":"10.1186/s12955-025-02334-6","url":null,"abstract":"<p><strong>Background: </strong>Laryngeal cancer often leads to total laryngectomy (TL), which results in the loss of natural voice, necessitates voice rehabilitation and affects the individuals Quality of Life (QoL). Despite advancements in treatment, Voice-Related QoL (VRQoL) post TL remains a neglected area in the field of rehabilitation. This study seeks to fill this gap by evaluating though a scoping review the impacts of TL on patients' voice-related QoL.</p><p><strong>Methods: </strong>A scoping review was conducted to assess the impact of total laryngectomy (TL) on voice-related quality of life (VRQoL). The search was performed across various electronic databases-PubMed, Scopus, Embase, Cohrane Library, Google scholar and Web of Science- using a broad set of keywords to capture studies addressing total laryngectomy and voice-related quality of life (VRQoL). Articles were screened using predefined inclusion and exclusion criteria, focusing on studies that directly addressed TL and VRQoL outcomes.</p><p><strong>Results: </strong>A total of eleven papers were finally selected to respond to the research question. The review indicates that TL significantly impacts VRQoL. Common issues included difficulties with communication in noisy environments, social interactions, anxiety about being understood, and physical challenges related to voice production. These difficulties were reflected in lower scores on various assessment tools. Patients reported declines in socio-emotional functioning and faced challenges in physical activities requiring voice use.</p><p><strong>Conclusions: </strong>This scoping review highlights the profound impact of TL on patients' voice-related QoL. Despite advances in surgical techniques and rehabilitation methods, patients continue to experience significant challenges in communication and social integration, which are crucial components of overall well-being. The persistent lower scores across various QoL assessment tools underscore the necessity for enhanced supportive care and innovative rehabilitation strategies tailored to the specific needs of this population.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"6"},"PeriodicalIF":3.2,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143004533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health utility scores of six common cancers in China measured by SF-6Dv2. 用SF-6Dv2测量中国六种常见癌症的健康效用得分。
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-12 DOI: 10.1186/s12955-025-02332-8
Yuchun Tao, Yiyin Cao, Lijun Xu, Jiaxuan Shi, Lei Leng, Hongbin Yang, Tiemin Zhai, Weidong Huang

Purpose: Given the recent update of SF-6Dv2, detailed data on utility scores for cancer patients by cancer type remain scarce in China and other regions, which limits the precision of cost-utility analyses (CUA) in cancer interventions. The aim of the study was to systematically evaluate utility scores of six common cancers in China measured using SF-6Dv2, and identify the potential factors associated with utility scores.

Methods: A hospital-based cross-sectional survey was conducted from August 2022 to December 2023. It recruited 896 cancer patients from three tertiary hospitals in China, including 270 with lung cancer, 96 with stomach cancer, 88 with liver cancer, 71 with oesophagus cancer, 142 with colorectum cancer, and 160 with breast cancer. The validated Simplified Chinese version of the SF-6Dv2 was used to calculate utilities based on the Chinese value set, and the utility values were described using the mean and standard deviation (SD). Participants' socio-demographic, behavioral and clinical characteristics were also obtained from the survey. Univariate and multivariate linear regression models were performed to explore the impact of these three categories of characteristics on utility scores derived from SF-6Dv2 for the total cancer patients and each cancer group.

Results: The mean utility score was 0.66 (SD = 0.26) for the total cancer sample, 0.66 (SD = 0.25) for lung cancer, 0.75 (SD = 0.23) for stomach cancer, 0.69 (SD = 0.24) for liver cancer, 0.69 (SD = 0.24) for oesophagus cancer, 0.65 (SD = 0.31) for colorectum cancer, and 0.57 (SD = 0.24) for breast cancer. Multivariate linear regression analysis indicated that patients who were older, from larger families, under greater economic pressures, undergoing fewer health examinations, smoking, and in advanced cancer stages had lower utility scores in the total cancer sample (p<0.05), with variations observed across different cancer types.

Conclusions: This study is one of the first to apply the SF-6Dv2 to a heterogeneous group of cancer patients, providing evidence for conducting CUA with SF-6Dv2 across six common cancers in China. In addition, the study provides a basis for improving interventions for different cancer types.

目的:鉴于SF-6Dv2最近更新,在中国和其他地区,按癌症类型划分的癌症患者效用评分的详细数据仍然缺乏,这限制了癌症干预中成本效用分析(CUA)的准确性。该研究的目的是系统地评估使用SF-6Dv2测量的中国六种常见癌症的效用得分,并确定与效用得分相关的潜在因素。方法:于2022年8月至2023年12月进行以医院为基础的横断面调查。从国内三家三级医院招募肿瘤患者896例,其中肺癌270例,胃癌96例,肝癌88例,食道癌71例,结直肠癌142例,乳腺癌160例。使用经过验证的简体中文版SF-6Dv2计算基于中文值集的效用,并使用均值和标准差(SD)描述效用值。参与者的社会人口学、行为和临床特征也从调查中获得。采用单变量和多变量线性回归模型来探讨这三类特征对SF-6Dv2对总癌症患者和每个癌症组的效用评分的影响。结果:总体癌症样本的平均效用评分为0.66 (SD = 0.26),肺癌为0.66 (SD = 0.25),胃癌为0.75 (SD = 0.23),肝癌为0.69 (SD = 0.24),食管癌为0.69 (SD = 0.24),结直肠癌为0.65 (SD = 0.31),乳腺癌为0.57 (SD = 0.24)。多变量线性回归分析表明,年龄较大、家庭成员较多、经济压力较大、健康检查较少、吸烟、癌症晚期的患者在总癌症样本中的效用得分较低(p结论:本研究首次将SF-6Dv2应用于异质癌症患者群体,为在中国6种常见癌症中使用SF-6Dv2进行CUA提供了证据。此外,该研究为改进针对不同癌症类型的干预措施提供了基础。
{"title":"Health utility scores of six common cancers in China measured by SF-6Dv2.","authors":"Yuchun Tao, Yiyin Cao, Lijun Xu, Jiaxuan Shi, Lei Leng, Hongbin Yang, Tiemin Zhai, Weidong Huang","doi":"10.1186/s12955-025-02332-8","DOIUrl":"10.1186/s12955-025-02332-8","url":null,"abstract":"<p><strong>Purpose: </strong>Given the recent update of SF-6Dv2, detailed data on utility scores for cancer patients by cancer type remain scarce in China and other regions, which limits the precision of cost-utility analyses (CUA) in cancer interventions. The aim of the study was to systematically evaluate utility scores of six common cancers in China measured using SF-6Dv2, and identify the potential factors associated with utility scores.</p><p><strong>Methods: </strong>A hospital-based cross-sectional survey was conducted from August 2022 to December 2023. It recruited 896 cancer patients from three tertiary hospitals in China, including 270 with lung cancer, 96 with stomach cancer, 88 with liver cancer, 71 with oesophagus cancer, 142 with colorectum cancer, and 160 with breast cancer. The validated Simplified Chinese version of the SF-6Dv2 was used to calculate utilities based on the Chinese value set, and the utility values were described using the mean and standard deviation (SD). Participants' socio-demographic, behavioral and clinical characteristics were also obtained from the survey. Univariate and multivariate linear regression models were performed to explore the impact of these three categories of characteristics on utility scores derived from SF-6Dv2 for the total cancer patients and each cancer group.</p><p><strong>Results: </strong>The mean utility score was 0.66 (SD = 0.26) for the total cancer sample, 0.66 (SD = 0.25) for lung cancer, 0.75 (SD = 0.23) for stomach cancer, 0.69 (SD = 0.24) for liver cancer, 0.69 (SD = 0.24) for oesophagus cancer, 0.65 (SD = 0.31) for colorectum cancer, and 0.57 (SD = 0.24) for breast cancer. Multivariate linear regression analysis indicated that patients who were older, from larger families, under greater economic pressures, undergoing fewer health examinations, smoking, and in advanced cancer stages had lower utility scores in the total cancer sample (p<0.05), with variations observed across different cancer types.</p><p><strong>Conclusions: </strong>This study is one of the first to apply the SF-6Dv2 to a heterogeneous group of cancer patients, providing evidence for conducting CUA with SF-6Dv2 across six common cancers in China. In addition, the study provides a basis for improving interventions for different cancer types.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"5"},"PeriodicalIF":3.2,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a PROM to measure patient-centredness in chronic care consultations in primary care. 一个PROM的发展,以衡量病人为中心的慢性护理咨询在初级保健。
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-08 DOI: 10.1186/s12955-024-02327-x
Anne Holm, Anna Bernhardt Lyhnebeck, Sussi Friis Buhl, Kristine Bissenbakker, Jette Kolding Kristensen, Anne Møller, Anders Prior, Zaza Kamper-Jørgensen, Sidsel Böcher, Mads Aage Toft Kristensen, Asger Waagepetersen, Anders Hye Dalsgaard, Volkert Siersma, Ann Dorrit Guassora, John Brandt Brodersen

Introduction: Validated patient-reported outcome measures (PROMs) are crucial for assessing patients' experiences in the healthcare system. Both clinically and theoretically, patient-centered consultations are essential in patient-care, and are often suggested as the optimal strategy in caring for patients with multimorbidity.

Aim: To either identify or develop and validate a patient-reported outcome measure (PROM) to assess patient-centredness in consultations for patients with multimorbidity in general practice.

Methods: We attempted to identify an existing PROM through a systematic literature review. If a suitable PROM was not identified, we planned to (1) construct a draft PROM based on items from existing PROMs, (2) conduct group and individual interviews among members of the target population to ensure comprehensibility, comprehensiveness and relevance, and (3) perform a psychometric validation in a broad sample of patients from primary care.

Results: We did not identify an eligible PROM in the literature review. The item extraction and face validity meetings resulted in a new PROM consisting of 47 items divided into five domains: biopsychosocial perspective; `patient-as-person'; sharing power and responsibility; therapeutic alliance; and coordinated care. The interviews resulted in a number of changes to the layout and phrasing as well as the deletion of items. The PROM used in the psychometric validation consisted of 28 items. Psychometric validation showed high internal consistency, overall high reliability, and moderate fit indices in the confirmatory factor analysis for all five domains. Few items demonstrated differential item functioning concerning variables such as age, sex, and education.

Conclusions: This study successfully developed and validated a PROM to measure patient-centredness in consultations for patients with multimorbidity. The five domains demonstrated high reliability and validity, making it a valuable tool for measuring patient-centredness of consultations in general practice.

Trial registration: Trial registration number (data for psychometric validation): https://clinicaltrials.gov : NCT05676541 Registration Date: 2022-12-16.

经过验证的患者报告结果测量(PROMs)对于评估患者在医疗保健系统中的经历至关重要。无论是临床还是理论上,以患者为中心的咨询在患者护理中都是必不可少的,并且经常被建议作为照顾多病患者的最佳策略。目的:确定或开发并验证患者报告的结果测量(PROM),以评估在全科实践中多病患者的咨询中以患者为中心。方法:我们试图通过系统的文献回顾来确定现有的PROM。如果没有确定合适的PROM,我们计划(1)根据现有PROM中的项目构建PROM草案,(2)在目标人群中进行小组和个人访谈,以确保可理解性、全面性和相关性,以及(3)在来自初级保健的患者的广泛样本中进行心理测量验证。结果:在文献回顾中,我们没有发现符合条件的PROM。项目提取和面对效度会议产生了一个由47个项目组成的新PROM,分为五个领域:生物心理社会视角;“patient-as-person”;分享权力和责任;联合治疗;协调护理。经过采访,报告的布局和措辞发生了一些变化,并删除了一些项目。心理测量验证采用的PROM共有28个项目。心理测量验证结果显示,验证性因子分析的内部一致性高,总体信度高,拟合指标适中。很少有项目表现出与年龄、性别和教育等变量相关的差异项目功能。结论:本研究成功地开发并验证了一种PROM,用于测量多病患者会诊时以患者为中心的程度。这五个领域证明了高可靠性和有效性,使其成为衡量以患者为中心的咨询在一般实践的宝贵工具。试验注册:试验注册号(心理测量验证数据):https://clinicaltrials.gov: NCT05676541注册日期:2022-12-16。
{"title":"Development of a PROM to measure patient-centredness in chronic care consultations in primary care.","authors":"Anne Holm, Anna Bernhardt Lyhnebeck, Sussi Friis Buhl, Kristine Bissenbakker, Jette Kolding Kristensen, Anne Møller, Anders Prior, Zaza Kamper-Jørgensen, Sidsel Böcher, Mads Aage Toft Kristensen, Asger Waagepetersen, Anders Hye Dalsgaard, Volkert Siersma, Ann Dorrit Guassora, John Brandt Brodersen","doi":"10.1186/s12955-024-02327-x","DOIUrl":"10.1186/s12955-024-02327-x","url":null,"abstract":"<p><strong>Introduction: </strong>Validated patient-reported outcome measures (PROMs) are crucial for assessing patients' experiences in the healthcare system. Both clinically and theoretically, patient-centered consultations are essential in patient-care, and are often suggested as the optimal strategy in caring for patients with multimorbidity.</p><p><strong>Aim: </strong>To either identify or develop and validate a patient-reported outcome measure (PROM) to assess patient-centredness in consultations for patients with multimorbidity in general practice.</p><p><strong>Methods: </strong>We attempted to identify an existing PROM through a systematic literature review. If a suitable PROM was not identified, we planned to (1) construct a draft PROM based on items from existing PROMs, (2) conduct group and individual interviews among members of the target population to ensure comprehensibility, comprehensiveness and relevance, and (3) perform a psychometric validation in a broad sample of patients from primary care.</p><p><strong>Results: </strong>We did not identify an eligible PROM in the literature review. The item extraction and face validity meetings resulted in a new PROM consisting of 47 items divided into five domains: biopsychosocial perspective; `patient-as-person'; sharing power and responsibility; therapeutic alliance; and coordinated care. The interviews resulted in a number of changes to the layout and phrasing as well as the deletion of items. The PROM used in the psychometric validation consisted of 28 items. Psychometric validation showed high internal consistency, overall high reliability, and moderate fit indices in the confirmatory factor analysis for all five domains. Few items demonstrated differential item functioning concerning variables such as age, sex, and education.</p><p><strong>Conclusions: </strong>This study successfully developed and validated a PROM to measure patient-centredness in consultations for patients with multimorbidity. The five domains demonstrated high reliability and validity, making it a valuable tool for measuring patient-centredness of consultations in general practice.</p><p><strong>Trial registration: </strong>Trial registration number (data for psychometric validation): https://clinicaltrials.gov : NCT05676541 Registration Date: 2022-12-16.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"4"},"PeriodicalIF":3.2,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142948029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-related quality of life and health state utility value in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. 特发性肺纤维化患者与健康相关的生活质量和健康状态效用价值:一项系统回顾和荟萃分析
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-05 DOI: 10.1186/s12955-024-02326-y
Guixiang Zhao, Siyuan Lei, Ya Li, Zhenzhen Feng, Jiansheng Li
<p><strong>Background: </strong>Idiopathic pulmonary fibrosis (IPF) is associated with high mortality, heavy economic burden, limited treatment options and poor prognosis, and seriously affects the health-related quality of life (HRQoL) and life expectancy of patients. This systematic review and meta-analysis of HRQoL and health state utility value (HSUV) in IPF patients and the instruments used in this assessment aimed to provide information sources and data support for the future research on IPF HRQoL and HSUV.</p><p><strong>Methods: </strong>We searched the PubMed, EMBASE, Web of Science and Cochrane Library databases for studies reporting the HRQoL or HSUV of IPF patients, with the retrieval time from the establishment of each database to April 2024. After two researchers independently screened the literature, extracted the data, and evaluated the risk of bias in the included studies, pooled analysis was performed on the measurement tools adopted in more than two studies. Subgroup analysis was employed to explore the source of heterogeneity, and sensitivity analysis was used to assess the robustness of the results. Funnel-plot directed evaluation combined with Egger's test quantitative evaluation was conducted to detect publication bias.</p><p><strong>Results: </strong>Sixty-nine studies were ultimately included, covering eighteen measurement tools. The literature quality was generally excellent. The St. George's Respiratory Questionnaire (SGRQ), EuroQoL Five Dimensions Questionnaire (EQ-5D), Short Form-36 (SF-36) and the King's Brief Interstitial Lung Disease (KBILD) were the most common instruments, among which the EQ-5D included the HSUV and the visual analog scale (VAS). The results of the meta-analysis revealed that the pooled SGRQ total score was 45.28 (95% confidence interval [CI] 41.10-49.47), the mean EQ-5D utility score was 0.75 (95% CI: 0.72-0.79), the total EQ-5D VAS score was 66.88 (95% CI: 63.75-70.01), and the pooled SF-36 physical component summary (PCS) and mental component summary (MCS) score were 36.70 (95% CI: 32.98-40.41) and 48.99 (95% CI: 47.44-50.55), respectively. The total KBILD score was 58.31 (95% CI: 55.43-61.19), the IPF specific version of the SGRQ (SGRQ-I) was 40.38 (95% CI: 28.81-51.96) and the Leicester Cough Questionnaire (LCQ) score was 16.09 (95% CI: 15.45-16.74). The pooled result of the University of California San Diego Shortness of Breath Questionnaire (USCD-SOBQ) was 45.05 (95% CI: 41.56-48.55). The results of other instruments, such as the tool to assess quality of life in IPF (ATAQ-IPF), the World Health Organization Quality of Life assessment 100 (WHOQoL-100) and the 12-item short-form health survey (SF-12) were similar to those of the above measurement tools. Regretfully, subgroup analyses did not identify the source of heterogeneity, but sensitivity analyses demonstrated robustness of our results. Except for the SGRQ total, our results showed little possibility of publication bias.</p><p><strong>
背景:特发性肺纤维化(Idiopathic pulmonary fibrosis, IPF)具有死亡率高、经济负担重、治疗选择有限、预后差等特点,严重影响患者健康相关生活质量(HRQoL)和预期寿命。本研究对IPF患者HRQoL和健康状态效用值(HSUV)的系统回顾和meta分析,以及评估中使用的工具,旨在为IPF HRQoL和HSUV的进一步研究提供信息来源和数据支持。方法:检索PubMed、EMBASE、Web of Science和Cochrane Library数据库中有关IPF患者HRQoL或HSUV的研究,检索时间从各数据库建立至2024年4月。两名研究者独立筛选文献、提取资料并评估纳入研究的偏倚风险后,对两项以上研究采用的测量工具进行汇总分析。采用亚组分析探讨异质性来源,采用敏感性分析评价结果的稳健性。采用漏斗图导向评价结合Egger检验定量评价来检测发表偏倚。结果:最终纳入69项研究,涵盖18种测量工具。文献质量总体上很好。圣乔治呼吸问卷(SGRQ)、EuroQoL五维度问卷(EQ-5D)、Short Form-36 (SF-36)和King's Brief间质性肺疾病(KBILD)是最常见的检测工具,其中EQ-5D包括HSUV和视觉模拟量表(VAS)。meta分析结果显示,合并SGRQ总分为45.28分(95%可信区间[CI] 41.10 ~ 49.47), EQ-5D效用评分均值为0.75分(95% CI: 0.72 ~ 0.79),合并EQ-5D VAS总分为66.88分(95% CI: 63.75 ~ 70.01),合并SF-36生理成分总结(PCS)和心理成分总结(MCS)评分分别为36.70分(95% CI: 32.98 ~ 40.41)和48.99分(95% CI: 47.44 ~ 50.55)。KBILD总分为58.31分(95% CI: 55.43 ~ 61.19), IPF特异性SGRQ (SGRQ- i)评分为40.38分(95% CI: 28.81 ~ 51.96),莱斯特咳嗽问卷(LCQ)评分为16.09分(95% CI: 15.45 ~ 16.74)。加州大学圣地亚哥分校呼吸短促问卷(USCD-SOBQ)的汇总结果为45.05 (95% CI: 41.56-48.55)。其他工具,如评估IPF生活质量的工具(ATAQ-IPF)、世界卫生组织生活质量评估100 (WHOQoL-100)和12项简短健康调查(SF-12)的结果与上述测量工具相似。遗憾的是,亚组分析没有确定异质性的来源,但敏感性分析证明了我们结果的稳健性。除了SGRQ总量外,我们的结果几乎不存在发表偏倚的可能性。结论:IPF患者HRQoL普遍较差,各领域均受到严重影响。随着病情的加重,HRQoL和HSUV呈现相对下降的趋势,收入水平也是影响HRQoL和HSUV的重要因素。目前已发表的IPF HRQoL和HSUV研究采用的测量工具较多,且研究间异质性较高,未来应加强对最佳疾病测量工具的研究。我们的研究为IPF HRQoL和HSUV提供了高质量的综合证据,可用于指导今后的临床和经济评价。
{"title":"Health-related quality of life and health state utility value in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.","authors":"Guixiang Zhao, Siyuan Lei, Ya Li, Zhenzhen Feng, Jiansheng Li","doi":"10.1186/s12955-024-02326-y","DOIUrl":"https://doi.org/10.1186/s12955-024-02326-y","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Idiopathic pulmonary fibrosis (IPF) is associated with high mortality, heavy economic burden, limited treatment options and poor prognosis, and seriously affects the health-related quality of life (HRQoL) and life expectancy of patients. This systematic review and meta-analysis of HRQoL and health state utility value (HSUV) in IPF patients and the instruments used in this assessment aimed to provide information sources and data support for the future research on IPF HRQoL and HSUV.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We searched the PubMed, EMBASE, Web of Science and Cochrane Library databases for studies reporting the HRQoL or HSUV of IPF patients, with the retrieval time from the establishment of each database to April 2024. After two researchers independently screened the literature, extracted the data, and evaluated the risk of bias in the included studies, pooled analysis was performed on the measurement tools adopted in more than two studies. Subgroup analysis was employed to explore the source of heterogeneity, and sensitivity analysis was used to assess the robustness of the results. Funnel-plot directed evaluation combined with Egger's test quantitative evaluation was conducted to detect publication bias.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Sixty-nine studies were ultimately included, covering eighteen measurement tools. The literature quality was generally excellent. The St. George's Respiratory Questionnaire (SGRQ), EuroQoL Five Dimensions Questionnaire (EQ-5D), Short Form-36 (SF-36) and the King's Brief Interstitial Lung Disease (KBILD) were the most common instruments, among which the EQ-5D included the HSUV and the visual analog scale (VAS). The results of the meta-analysis revealed that the pooled SGRQ total score was 45.28 (95% confidence interval [CI] 41.10-49.47), the mean EQ-5D utility score was 0.75 (95% CI: 0.72-0.79), the total EQ-5D VAS score was 66.88 (95% CI: 63.75-70.01), and the pooled SF-36 physical component summary (PCS) and mental component summary (MCS) score were 36.70 (95% CI: 32.98-40.41) and 48.99 (95% CI: 47.44-50.55), respectively. The total KBILD score was 58.31 (95% CI: 55.43-61.19), the IPF specific version of the SGRQ (SGRQ-I) was 40.38 (95% CI: 28.81-51.96) and the Leicester Cough Questionnaire (LCQ) score was 16.09 (95% CI: 15.45-16.74). The pooled result of the University of California San Diego Shortness of Breath Questionnaire (USCD-SOBQ) was 45.05 (95% CI: 41.56-48.55). The results of other instruments, such as the tool to assess quality of life in IPF (ATAQ-IPF), the World Health Organization Quality of Life assessment 100 (WHOQoL-100) and the 12-item short-form health survey (SF-12) were similar to those of the above measurement tools. Regretfully, subgroup analyses did not identify the source of heterogeneity, but sensitivity analyses demonstrated robustness of our results. Except for the SGRQ total, our results showed little possibility of publication bias.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"3"},"PeriodicalIF":3.2,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lived experiences of dysphagia-related quality of life among esophageal cancer patients: a qualitative study. 食道癌患者与吞咽困难相关的生活质量体验:一项定性研究。
IF 3.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-01-05 DOI: 10.1186/s12955-024-02319-x
Tseganesh Asefa, Winta Tesfaye, Gedamnesh Bitew, Hiwot Tezera

Introduction: Esophageal cancer impairs basic functions such as eating and drinking frequently resulting in difficulty swallowing (dysphagia) and other problems such as weight loss, pain, fatigue, and taste alterations. There is still a research gap in understanding the impact of dysphagia on quality of life, as patients continue to bear significant physical and psychological burdens despite advances in treatment. This study attempted to address this gap by examining the lived experiences of dysphagia-related quality of life among esophageal cancer patients.

Methods: A phenomenological study was employed to analyze the data provided by 14 patients with esophageal cancer at the Oncology Center of the University of Gondar Comprehensive Specialized Hospital from March to April 2023. An interview guide was employed to carry out in-depth interviews with purposively selected patients. The interviews were audio-taped, translated, transcribed, and analysed using thematic analysis.

Results: Three main themes emerged from the analysis of the participant interviews: physical challenges related to difficulty swallowing, altered dietary habits, and struggle to maintain weight; psychosocial strain, including emotional distress and social isolation; and reliance on assistance, encompassing both dependency and financial burden.

Conclusion and recommendations: This study underscores the significant physical, emotional, and social challenges experienced by esophageal cancer patients with dysphagia. To enhance support, healthcare providers should develop personalized care plans that address both the physical and emotional aspects of dysphagia, with sensitivity to cultural practices. Efforts should also be made to alleviate feelings of dependency and promote public awareness to reduce stigma and build a more supportive community.

食管癌损害基本功能,如频繁进食和饮水,导致吞咽困难(吞咽困难)和其他问题,如体重减轻、疼痛、疲劳和味觉改变。在理解吞咽困难对生活质量的影响方面仍然存在研究空白,因为尽管治疗取得了进展,但患者仍然承受着巨大的身体和心理负担。本研究试图通过检查食管癌患者与吞咽困难相关的生活质量的生活经历来解决这一差距。方法:采用现象学方法对贡达尔大学综合专科医院肿瘤中心于2023年3月至4月收治的14例食管癌患者资料进行分析。采用访谈指南对有目的选择的患者进行深度访谈。访谈录音、翻译、转录,并使用专题分析进行分析。结果:从参与者访谈的分析中出现了三个主要主题:与吞咽困难、饮食习惯改变和努力保持体重有关的身体挑战;心理压力,包括情绪困扰和社会孤立;对援助的依赖,包括依赖和经济负担。结论和建议:本研究强调食管癌吞咽困难患者所经历的重大身体、情感和社会挑战。为了加强支持,医疗保健提供者应该制定个性化的护理计划,解决吞咽困难的身体和情感方面的问题,并对文化习俗敏感。还应努力减轻依赖感,提高公众意识,以减少耻辱感,建立一个更加支持的社区。
{"title":"Lived experiences of dysphagia-related quality of life among esophageal cancer patients: a qualitative study.","authors":"Tseganesh Asefa, Winta Tesfaye, Gedamnesh Bitew, Hiwot Tezera","doi":"10.1186/s12955-024-02319-x","DOIUrl":"https://doi.org/10.1186/s12955-024-02319-x","url":null,"abstract":"<p><strong>Introduction: </strong>Esophageal cancer impairs basic functions such as eating and drinking frequently resulting in difficulty swallowing (dysphagia) and other problems such as weight loss, pain, fatigue, and taste alterations. There is still a research gap in understanding the impact of dysphagia on quality of life, as patients continue to bear significant physical and psychological burdens despite advances in treatment. This study attempted to address this gap by examining the lived experiences of dysphagia-related quality of life among esophageal cancer patients.</p><p><strong>Methods: </strong>A phenomenological study was employed to analyze the data provided by 14 patients with esophageal cancer at the Oncology Center of the University of Gondar Comprehensive Specialized Hospital from March to April 2023. An interview guide was employed to carry out in-depth interviews with purposively selected patients. The interviews were audio-taped, translated, transcribed, and analysed using thematic analysis.</p><p><strong>Results: </strong>Three main themes emerged from the analysis of the participant interviews: physical challenges related to difficulty swallowing, altered dietary habits, and struggle to maintain weight; psychosocial strain, including emotional distress and social isolation; and reliance on assistance, encompassing both dependency and financial burden.</p><p><strong>Conclusion and recommendations: </strong>This study underscores the significant physical, emotional, and social challenges experienced by esophageal cancer patients with dysphagia. To enhance support, healthcare providers should develop personalized care plans that address both the physical and emotional aspects of dysphagia, with sensitivity to cultural practices. Efforts should also be made to alleviate feelings of dependency and promote public awareness to reduce stigma and build a more supportive community.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":"23 1","pages":"2"},"PeriodicalIF":3.2,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142931620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health and Quality of Life Outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1